Characteristics of gray matter alterations in never-treated and treated chronic schizophrenia patients

• Published in: Translational psychiatry Vol. 10; no. 1; p. 136
• Main Authors: Liu, Nian, Xiao, Yuan, Zhang, Wenjing, Tang, Biqiu, Zeng, Jiaxin, Hu, Na, Chandan, Shah, Gong, Qiyong, Lui, Su
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 12.05.2020; Nature Publishing Group
• Subjects: 59/57; 631/154/436/108; 692/699/476/1799; Antipsychotic Agents - therapeutic use; Antipsychotics; Behavioral Sciences; Biological Psychology; Clozapine - therapeutic use; Gray Matter - diagnostic imaging; Humans; Magnetic Resonance Imaging; Medicine; Medicine & Public Health; Neurosciences; Pharmacotherapy; Psychiatry; Psychotropic drugs; Schizophrenia; Schizophrenia - drug therapy

Though gray matter deficits have been consistently revealed in chronic treated schizophrenia, it is still not clear whether there are different brain alterations between chronic never treated and treated patients. To explore the different patterns of gray matter alterations among chronic never treat...